CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE344.85-9.25 (-2.61 %)
PREV CLOSE ( ) 354.10
OPEN PRICE ( ) 359.70
BID PRICE (QTY) 344.40 (124)
OFFER PRICE (QTY) 344.85 (64)
VOLUME 76424
TODAY'S LOW / HIGH ( )343.25 359.70
52 WK LOW / HIGH ( )341.65 554.2
NSE344.75-9.5 (-2.68 %)
PREV CLOSE( ) 354.25
OPEN PRICE ( ) 357.70
BID PRICE (QTY) 344.70 (281)
OFFER PRICE (QTY) 344.75 (57)
VOLUME 1162707
TODAY'S LOW / HIGH( ) 343.60 357.70
52 WK LOW / HIGH ( )341.2 554.9
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Formulation Units,Zydus Tower,Satellite Cross Roads,
Ahmedabad,
Gujarat-380015

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX
NEWS
19Jul Zydus Cadila gets final approval from
Zydus Cadila has received the final approval from the US Food and Drug A..
18Jul Zydus Cadila receives four consecutive
Zydus Cadila has received four consecutive final approvals from the US F..
18Jul Cadila Healthcare trades in green on t
Cadila Healthcare is currently trading at Rs. 361.25, up by 1.75 points..
18Jul Cadila Healthcare informs about press
Cadila Healthcare has informed about press release titled, ' Zydus recei..
17Jul Zydus Cadila receives final approval f
Zydus Cadila has received the final approval from the US Food and Drug A..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit243210908
Gross Profit 3152 14972
Operating Profit 419218542
Net Sales 1455158226
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7269.95 (1.26%)
M.Cap (Rs. in Cr)15371.21
Astrazeneca Pharma I (BSE)
 1467.60 (3.08%)
M.Cap (Rs. in Cr)3661.38
Zim Laboratories (BSE)
 367.00 (4.86%)
M.Cap (Rs. in Cr)295.79
Hester Biosciences (BSE)
 1176.05 (1.12%)
M.Cap (Rs. in Cr)1000.45
Merck (BSE)
 2254.45 (0.44%)
M.Cap (Rs. in Cr)3679.25
Shareholding Pattern
PROMOTERS 74.79%
NON-INSTITUTION 7.84%
MUTUAL FUNDS/UTI 5.03%
FI/BANKS/INSURANCE 3.53%
GOVERNMENT 0.09%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.